The enrichment of marginal zone B cells as well as progressive expansion of splenic white pulp and development of B-cell lymphomas in NIAM mutant mice supports the prediction that NF-κB signaling may be hyper-activated when NIAM is down-regulated. The gene discussed is NFKB1; the disease is B-cell non-Hodgkin lymphoma.